RESOURCE UTILIZATION AND COSTS AMONG PATIENTS WITH GLYCOGEN STORAGE DISEASE TYPE IA (GSDIA)

被引：0
|
作者：
Nedzesky, J. [1 ]
Kruger, E. [2 ]
Thomas, N. A. [3 ]
Valayannopoulos, V. [4 ]
Poma, A. [4 ]
机构：
[1] Ultragenyx Pharmaceut Ltd, Brisbane, CA USA
[2] Ultragenyx Pharmaceut Ltd, San Francisco, CA USA
[3] Ultragenyx Pharmaceut Inc Ltd, Brisbane, CA USA
[4] Ultragenyx Pharmaceut Ltd, Cambridge, MA USA
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRO76
引用
收藏
页码：S212 / S212
页数：1
相关论文
共 50 条
  • [31] Evaluation of central nervous system in patients with glycogen storage disease type IA
    Gurakan, F.
    Aydemir, Y.
    Yuce, A.
    Saltik-Temizel, I. N.
    Demir, H.
    Yalnizoglu, D.
    Topcu, M.
    Usta, Y.
    Ozen, H.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 44 : 163 - 163
  • [32] Stone Forming Risk Factors in Patients With Type Ia Glycogen Storage Disease
    Scales, Charles D., Jr.
    Chandrashekar, Aravind S.
    Robinson, Marnie R.
    Cantor, David A.
    Sullivan, Jennifer
    Haleblian, George E.
    Leitao, Victor A.
    Sur, Roger L.
    Borawski, Kristy M.
    Koeberl, Dwight
    Kishnani, Priya S.
    Preminger, Glenn M.
    JOURNAL OF UROLOGY, 2010, 183 (03): : 1022 - 1025
  • [33] A pediatric patient with glycogen storage disease type IA and Castleman disease
    Cuglievan, Branko
    Menegaz, Brian A.
    DePombo, April
    Morani, Ajaykumar C.
    Miranda, Roberto N.
    Rytting, Michael
    PEDIATRIC BLOOD & CANCER, 2017, 64 (08)
  • [34] Activation of glycolysis and apoptosis in glycogen storage disease type Ia
    Sun, Baodong
    Li, Songtao
    Yang, Liu
    Damodaran, Tirupapuliyur
    Desai, Dev
    Diehl, Anna Mae
    Alzate, Oscar
    Koeberl, Dwight D.
    MOLECULAR GENETICS AND METABOLISM, 2009, 97 (04) : 267 - 271
  • [35] Molecular prenatal diagnosis of glycogen storage disease type Ia
    Qu, Y
    Abdenur, JE
    Eng, CM
    Desnick, RJ
    PRENATAL DIAGNOSIS, 1996, 16 (04) : 333 - 336
  • [36] Hepatocyte transplantation as a treatment for glycogen storage disease type IA
    Muraca, M
    Gerunda, G
    Neri, D
    Vilei, MT
    Granato, A
    Feltracco, P
    Giron, G
    Burlina, AB
    JOURNAL OF HEPATOLOGY, 2002, 36 : 41 - 41
  • [37] CONTINUOUS GLUCOSE MONITORING IN GLYCOGEN STORAGE DISEASE TYPE IA
    Tinti, D.
    Giorda, S.
    Porta, F.
    Trada, M.
    Spada, M.
    De Sanctis, L.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A126 - A127
  • [38] Hemophagocytic Lymphohystiocytosis Associated With Type Ia Glycogen Storage Disease
    Kar, Yeter Duzenli
    Ozdemir, Zeynep C.
    Kiral, Eylem
    Yildirim, Gonca Kilic
    Dinleyici, Ener C.
    Bor, Ozcan
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (04) : E260 - E262
  • [39] High biotinidase activity in type Ia glycogen storage disease
    Saltik, IN
    Özen, H
    Koçak, N
    Yüce, A
    Gurakan, F
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (08): : 2144 - 2144
  • [40] Continuous glucose monitoring in the treatment of obesity in patients with glycogen storage disease type Ia
    Jelaska, Betty Korljan
    Ostojic, Sanja Barsic
    Berovic, Nina
    Kokic, Visnja
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2014,
12345